News November 2016 Issue

In the News: November 2016

In the News: November 2016

Many people with rheumatoid arthritis take biologic drugs, which differ from traditional drugs in that they are produced by living cells. This makes it difficult to produce cheaper generic versions. Biosimilar drugs, which are approximate copies that have the same therapeutic effect, have been created to replace traditional generic drugs. In a study published in August 2016, researchers analyzed results of 19 studies of five biologic drugs and their biosimilar counterparts.

To continue reading this article you must be a paid subscriber.

Subscribe to Arthritis Advisor

Arthritis Advisor is the first magazine published by one one of the world's leading orthopaedic hospitals specifically for people with arthritis.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.